Advocacy and educational support provided in part by:

Dr. Stefan Gluck sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss personalized medicine as well as the need for more efficient tissue and biospecimen collection for cancer research.

Stefan Gluck, MD is a Professor of Medicine, University of Miami, Associate Division Chief for Clinical Affaris, Division of Hematology/Oncology Sylvester Comprehensive Cancer Center, University of Miami Health Systems and the Clinical Director, Braman Family Breast Cancer Institute.

Advocacy and educational support provided in part by:

Dr. Christopher Twelves sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss the results of the Phase III clinical trial comparing capecitabine (Xeloda) and eribulin (Halaven).  The trial showed trends toward the superiority of eribulin in this setting but the results were still considered to be statistically negative overall, but not for triple-negative breast cancer patients.

Christopher Twelves, MD, Professor and Honorary Consultant in Medical Oncology, University of Leeds in the United Kingdom.

Advocacy and educational support provided in part by:

Dr. Joanne Mortimer sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss research being conducted at the City Of Hope Cancer Center on the functional imaging of HER2-positive metastatic breast cancer.

Joanne Mortimer, MD is the Vice Chair, Medical Oncology & Therapeutics Research — Director, Women’s Cancer Programs, Co-director, Breast Cancer Program — Administrative Director of Phase I Programs — Associate Director for Affiliate Programs — Professor of Medical Oncology — Member, Cancer Immunotherapeutics Program, all at the City Of Hope Comprehensive Cancer Center in Duarte, California.

Advocacy and educational support provided in part by:

Dr. Richard S. Finn sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss  the combination of PD 0332991 and letrozole phase II clinical trial results.

Richard S. Finn, MD is Associate Professor at the Jonsson Comprehensive Cancer Center at UCLA.

Advocacy and educational support provided in part by:

Dr. Martine Piccart sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss how cancer patients and advocates can help lead the way for tissue and biospecimen collection for cancer research.

Martine Piccart, MD, PhD is the current President of the European Society For Medical Oncology (ESMO) and Professor of Oncology at the Université Libre de Bruxelles (ULB) and Director of the Medicine Department at the Institut Jules Bordet, in Brussels, Belgium.

Advocacy and educational support provided in part by:

Dr. Martine Piccart sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss the results of a study she authored for patients with human epidermal growth factor receptor 2 (HER2)–positive early–stage breast cancer — one year of adjuvant trastuzumab (Herceptin) should remain the standard of care, according to a study presented.

Martine Piccart, MD, PhD is the current President of the European Society For Medical Oncology (ESMO) and Professor of Oncology at the Université Libre de Bruxelles (ULB) and Director of the Medicine Department at the Institut Jules Bordet, in Brussels, Belgium.

Advocacy and educational support provided in part by:

Dr. Edith Perez sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss her recent research with Anti-HER2 therapies presented at SABCS 2012.

Edith A. Perez, MD is Deputy Director, Mayo Clinic Cancer Center — Group Vice Chair, Alliance for Clinical Trials in Oncology — Serene M. and Frances C. Durling Professor of Medicine, Division of Hematology/Oncology, University of Miami, Mayo Medical School, Jacksonville, Florida

Advocacy and educational support provided in part by:

Dr. Larry Norton sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) for a three-part interview.  This is the first in the three-part interview where he discusses the rapidly changing face of oncology and personalized medicine.

Larry Norton, MD is the Deputy Physician-in-Chief for Breast Cancer Programs; Medical Director, Evelyn H. Lauder Breast Center; Norna S. Sarofim Chair in Clinical Oncology at Memorial Sloan-Kettering Cancer Center.

Advocacy and educational support provided in part by:

]]> http://thegrouproom.tv/larry-norton-md-the-rapidly-changing-face-of-oncology/2013/03/03/feed/ 0 http://thegrouproom.tv/larry-norton-md-the-challenging-role-for-patients-in-their-cancer-care/2013/03/03/ http://thegrouproom.tv/larry-norton-md-the-challenging-role-for-patients-in-their-cancer-care/2013/03/03/#comments Sun, 03 Mar 2013 17:20:12 +0000 thegrouproom http://thegrouproom.tv/?p=3741

Dr. Larry Norton sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) for a three-part interview.  This is the second in the three-part interview where he discusses the role of patients and advocates in the changing face of cancer care.

Larry Norton, MD is the Deputy Physician-in-Chief for Breast Cancer Programs; Medical Director, Evelyn H. Lauder Breast Center; Norna S. Sarofim Chair in Clinical Oncology at Memorial Sloan-Kettering Cancer Center.

Advocacy and educational support provided in part by:

]]> http://thegrouproom.tv/larry-norton-md-the-challenging-role-for-patients-in-their-cancer-care/2013/03/03/feed/ 0